Literature DB >> 22949185

The role of active-site Phe87 in modulating the organic co-solvent tolerance of cytochrome P450 BM3 monooxygenase.

Jochen Kuper1, Kang Lan Tee, Matthias Wilmanns, Danilo Roccatano, Ulrich Schwaneberg, Tuck Seng Wong.   

Abstract

Understanding the effects of organic co-solvents on protein structure and function is pivotal to engineering enzymes for biotransformation in non-aqueous solvents. The effects of DMSO on the catalytic activity of cytochrome P450 BM3 have previously been investigated and the importance of Phe87 in its organic co-solvent tolerance was identified. To probe the DMSO inactivation mechanism and the functional role of Phe87 in modulating the organic co-solvent tolerance of P450 BM3, the haem domain (Thr1-Leu455) of the F87A variant was cocrystallized in the presence of 14%(v/v) and 28%(v/v) DMSO. At both DMSO concentrations the protein retained the canonical structure of the P450 haem domain without any sign of partial or global unfolding. Interestingly, a DMSO molecule was found in the active site of both structures, with its O atom pointing towards the haem iron. The orientation of the DMSO molecule indicated a dynamic coordination process that was in competition with the active-site water molecule. The ability of the DMSO molecule to coordinate the haem iron is plausibly the main reason why P450 BM3 is inactivated at elevated DMSO concentrations. The data allowed an interesting comparison with the wild-type structures reported previously. A DMSO molecule was found when the wild-type protein was placed in 28%(v/v) DMSO, in which the DMSO molecule coordinated the haem iron directly via its S atom. Intriguingly, no DMSO molecule was observed at 14%(v/v) DMSO for the wild-type structure. These results suggested that the bulky phenyl side chain of Phe87 protects the haem from being accessed by the DMSO molecule and explains the higher tolerance of the wild-type enzyme towards organic co-solvents compared with its F87A variant.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22949185      PMCID: PMC3433188          DOI: 10.1107/S1744309112031570

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  18 in total

1.  Roles of key active-site residues in flavocytochrome P450 BM3.

Authors:  M A Noble; C S Miles; S K Chapman; D A Lysek; A C MacKay; G A Reid; R P Hanzlik; A W Munro
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

2.  A continuous spectrophotometric assay for P450 BM-3, a fatty acid hydroxylating enzyme, and its mutant F87A.

Authors:  U Schwaneberg; C Schmidt-Dannert; J Schmitt; R D Schmid
Journal:  Anal Biochem       Date:  1999-05-01       Impact factor: 3.365

3.  Protein engineering of Bacillus megaterium CYP102. The oxidation of polycyclic aromatic hydrocarbons.

Authors:  A B Carmichael; L L Wong
Journal:  Eur J Biochem       Date:  2001-05

Review 4.  P450 BM3: the very model of a modern flavocytochrome.

Authors:  Andrew W Munro; David G Leys; Kirsty J McLean; Ker R Marshall; Tobias W B Ost; Simon Daff; Caroline S Miles; Stephen K Chapman; Dominikus A Lysek; Christopher C Moser; Christopher C Page; P Leslie Dutton
Journal:  Trends Biochem Sci       Date:  2002-05       Impact factor: 13.807

5.  Structure of a cytochrome P450-redox partner electron-transfer complex.

Authors:  I F Sevrioukova; H Li; H Zhang; J A Peterson; T L Poulos
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

6.  The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid.

Authors:  H Li; T L Poulos
Journal:  Nat Struct Biol       Date:  1997-02

7.  Cost-effective whole-cell assay for laboratory evolution of hydroxylases in Escherichia coli.

Authors:  U Schwaneberg; C Otey; P C Cirino; E Farinas; F H Arnold
Journal:  J Biomol Screen       Date:  2001-04

8.  An active site substitution, F87V, converts cytochrome P450 BM-3 into a regio- and stereoselective (14S,15R)-arachidonic acid epoxygenase.

Authors:  S Graham-Lorence; G Truan; J A Peterson; J R Falck; S Wei; C Helvig; J H Capdevila
Journal:  J Biol Chem       Date:  1997-01-10       Impact factor: 5.157

9.  Laboratory evolution of cytochrome p450 BM-3 monooxygenase for organic cosolvents.

Authors:  Tuck Seng Wong; Frances H Arnold; Ulrich Schwaneberg
Journal:  Biotechnol Bioeng       Date:  2004-02-05       Impact factor: 4.530

10.  REFMAC5 for the refinement of macromolecular crystal structures.

Authors:  Garib N Murshudov; Pavol Skubák; Andrey A Lebedev; Navraj S Pannu; Roberto A Steiner; Robert A Nicholls; Martyn D Winn; Fei Long; Alexei A Vagin
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18
View more
  5 in total

1.  Structural insights into the mechanism of the drastic changes in enzymatic activity of the cytochrome P450 vitamin D3 hydroxylase (CYP107BR1) caused by a mutation distant from the active site.

Authors:  Yoshiaki Yasutake; Tomoshi Kameda; Tomohiro Tamura
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-04-26       Impact factor: 1.056

2.  Key mutations alter the cytochrome P450 BM3 conformational landscape and remove inherent substrate bias.

Authors:  Christopher F Butler; Caroline Peet; Amy E Mason; Michael W Voice; David Leys; Andrew W Munro
Journal:  J Biol Chem       Date:  2013-07-03       Impact factor: 5.157

3.  Dimethyl Sulfoxide Decreases Levels of Oxylipin Diols in Mouse Liver.

Authors:  Poonamjot Deol; Jun Yang; Christophe Morisseau; Bruce D Hammock; Frances M Sladek
Journal:  Front Pharmacol       Date:  2019-05-29       Impact factor: 5.810

4.  Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs.

Authors:  Laura N Jeffreys; Harshwardhan Poddar; Marina Golovanova; Colin W Levy; Hazel M Girvan; Kirsty J McLean; Michael W Voice; David Leys; Andrew W Munro
Journal:  Sci Rep       Date:  2019-02-07       Impact factor: 4.379

5.  Genetic fusion of P450 BM3 and formate dehydrogenase towards self-sufficient biocatalysts with enhanced activity.

Authors:  Arsenij Kokorin; Pavel D Parshin; Patrick J Bakkes; Anastasia A Pometun; Vladimir I Tishkov; Vlada B Urlacher
Journal:  Sci Rep       Date:  2021-11-04       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.